(VIANEWS) – HomeTrust Bancshares (HTBI), Consolidated Water Co. Ltd. (CWCO), VirTra (VTSI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. HomeTrust Bancshares (HTBI)
36.9% sales growth and 8.35% return on equity
HomeTrust Bancshares, Inc. operates as the bank holding company for HomeTrust Bank that provides a range of retail and commercial banking products and services. Its deposit products include savings, money market, and demand accounts, as well as certificates of deposit for individuals, businesses, and nonprofit organizations. The company's loan portfolio comprises retail consumer loans, such as one-to-four-family real estate lending, home equity lines of credit, construction and land/lots, indirect auto finance, and consumer lending; and commercial loans that include commercial real estate lending, construction and development lending, and commercial and industrial loans. It also provides small business administration loans, equipment finance leases, indirect automobile loans, and municipal leases; and cash management and online/mobile banking services. As of June 30, 2020, the company operated 41 offices in North Carolina, Upstate South Carolina, East Tennessee, and Southwest Virginia. HomeTrust Bancshares, Inc. was founded in 1926 and is headquartered in Asheville, North Carolina.
Earnings Per Share
As for profitability, HomeTrust Bancshares has a trailing twelve months EPS of $2.29.
PE Ratio
HomeTrust Bancshares has a trailing twelve months price to earnings ratio of 8.83. Meaning, the purchaser of the share is investing $8.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.35%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.8%, now sitting on 157.94M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 134.2% and 41.7%, respectively.
2. Consolidated Water Co. Ltd. (CWCO)
32.8% sales growth and 6.57% return on equity
Consolidated Water Co. Ltd., together with its subsidiaries, designs, constructs, manages, and operates water production and water treatment plants primarily in the Cayman Islands, the Bahamas, and the United States. The company operates through four segments: Retail, Bulk, Services, and Manufacturing. It uses reverse osmosis technology to produce potable water from seawater. The company produces and supplies water to end-users, including residential, commercial, and government customers, as well as government-owned distributors. It also provides design, engineering, construction, procurement, and management services for desalination projects and water treatment plants, as well as management and engineering services relating to municipal water distribution and treatment. In addition, the company manufactures and services a range of water-related products, including reverse osmosis desalination equipment, membrane separation equipment, filtration equipment, piping systems, vessels, and custom fabricated components; and provides design, engineering, consulting, management, inspection, training, and equipment maintenance services for commercial, municipal, and industrial water production, supply, and treatment, as well as desalination and wastewater treatment. Consolidated Water Co. Ltd. was incorporated in 1973 and is headquartered in Grand Cayman, the Cayman Islands.
Earnings Per Share
As for profitability, Consolidated Water Co. Ltd. has a trailing twelve months EPS of $0.65.
PE Ratio
Consolidated Water Co. Ltd. has a trailing twelve months price to earnings ratio of 29.78. Meaning, the purchaser of the share is investing $29.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.57%.
3. VirTra (VTSI)
29.6% sales growth and 12.61% return on equity
VirTra, Inc. provides force training simulators, firearms training simulators, and driving simulators for law enforcement, military, educational, and civilian worldwide. The company's products comprise V-300 simulator, a 300 degree wrap-around screen for simulation training; V-180 simulator, a 180 degree screen for smaller spaces or budgets; V-100, a single-screen based simulator system; V-100 MIL, a single-screen small arms training simulator; and V-ST PRO, a realistic single screen firearms shooting and skills training simulator. It also offers V-Author, a software that allows users to create, edit, and train with content specific to agency's objectives; Simulated Recoil Kits, a range of realistic and reliable simulated recoil kits/weapons; and Threat-Fire, a return fire device that applies real-world stress on the trainees during simulation training. In addition, the company provides VirTra Driving Sim, a vehicle-based simulator; Virtual Interactive Coursework Training Academy, which enables law enforcement agencies to each, train, test, and sustain departmental training requirements; Subscription Training Equipment Partnership, a program that allows agencies to utilize VirTra's simulator products, accessories, and V-VICTA interactive coursework on a subscription basis; and TASER, an OC spray and low-light training devices. It sells its simulators and related products through a direct sales force and distribution partners. The company was formerly known as VirTra Systems, Inc. and changed its name to VirTra, Inc. in October 2016. VirTra, Inc. was founded in 1993 and is based in Tempe, Arizona.
Earnings Per Share
As for profitability, VirTra has a trailing twelve months EPS of $0.4.
PE Ratio
VirTra has a trailing twelve months price to earnings ratio of 19.5. Meaning, the purchaser of the share is investing $19.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.61%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VirTra’s EBITDA is 2.46.
Moving Average
VirTra’s value is way above its 50-day moving average of $5.83 and way above its 200-day moving average of $5.15.
Volume
Today’s last reported volume for VirTra is 114560 which is 30.77% above its average volume of 87604.
4. Boston Scientific (BSX)
8.4% sales growth and 5.18% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $0.58.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 87.42. Meaning, the purchaser of the share is investing $87.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.18%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 11.4% and 11.6%, respectively.
Moving Average
Boston Scientific’s value is below its 50-day moving average of $51.53 and way above its 200-day moving average of $45.96.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12%, now sitting on 13.05B for the twelve trailing months.
Yearly Top and Bottom Value
Boston Scientific’s stock is valued at $50.71 at 01:22 EST, below its 52-week high of $54.17 and way above its 52-week low of $34.98.
Previous days news about Boston Scientific(BSX)
- According to Zacks on Tuesday, 6 June, "Some better-ranked stocks in the broader medical space are Hologic, Inc. (HOLX Quick QuoteHOLX – Free Report) , Merit Medical Systems, Inc. (MMSI Quick QuoteMMSI – Free Report) and Boston Scientific Corporation (BSX Quick QuoteBSX – Free Report) ."
- According to Zacks on Tuesday, 6 June, "A few other top-ranked stocks in the broader medical space that have announced quarterly results are Hologic, Inc. (HOLX Quick QuoteHOLX – Free Report) , Merit Medical Systems, Inc. (MMSI Quick QuoteMMSI – Free Report) and Boston Scientific Corporation (BSX Quick QuoteBSX – Free Report) ."
- According to Zacks on Wednesday, 7 June, "A few other top-ranked stocks in the broader medical space are Hologic, Inc. (HOLX Quick QuoteHOLX – Free Report) , Merit Medical Systems, Inc. (MMSI Quick QuoteMMSI – Free Report) and Boston Scientific Corporation (BSX Quick QuoteBSX – Free Report) ."
5. Modine Manufacturing Company (MOD)
5.5% sales growth and 15.29% return on equity
Modine Manufacturing Company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications. It operates through Vehicular Thermal Solutions, Commercial and Industrial Solutions, and Building HVAC Systems segments. The company offers powertrain cooling products, including engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, such as power steering and transmission oil coolers; component assemblies; radiators for special applications; on-engine cooling products comprising exhaust gas recirculation, engine oil, fuel, charge air, and intake air coolers; and chillers and cooling plates for battery thermal management. It also provides heat-exchanger and microchannel coils; unit, fluid, transformer oil, and brine coolers, as well as remote condensers; and coatings to protect against corrosion. In addition, the company offers gas-fired, hydronic, electric, and oil-fired unit heaters; indoor and outdoor duct furnaces; infrared units; hydronic products, such as commercial fin-tube radiation, cabinet unit heaters, and convectors; roof-mounted direct- and indirect-fired makeup air units; commercial packaged rooftop ventilation units; unit ventilators; single packaged vertical units; precision air conditioning units for data center applications; air-handling units; chillers; ceiling cassettes; hybrid fan coils; and condensing units. It serves automobile, truck, bus, and specialty vehicle OEMs; agricultural, industrial, and construction equipment OEMs; commercial and industrial equipment OEMs; heating, ventilation, and cooling OEMs; construction architects and contractors; and wholesalers of heating equipment. The company has operations in North America, South America, Europe, the Asia/Pacific, the Middle East, and Africa. Modine Manufacturing Company was founded in 1916 and is headquartered in Racine, Wisconsin.
Earnings Per Share
As for profitability, Modine Manufacturing Company has a trailing twelve months EPS of $1.34.
PE Ratio
Modine Manufacturing Company has a trailing twelve months price to earnings ratio of 15.85. Meaning, the purchaser of the share is investing $15.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.29%.
